-transparent.png){kind=logo}
Dose-related changes of the reduced glutathione were evaluated in forebrains from male Wistar rats aged 10 months after chronic i.p. treatment for two months with the ergot alkaloids dihydroergocristine and dihydroergocriptine. The results indicate that, within a specific dose-range, the concentration of the cerebral reduced glutathione may be modified by exogenous intervention.
Related Publications
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
January 1965,
Pharmaceutica acta Helvetiae,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
September 1951,
Klinische Wochenschrift,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
October 1957,
Pharmaceutica acta Helvetiae,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
June 1978,
Mutation research,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
January 1972,
Acta pharmacologica et toxicologica,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
November 1945,
Experientia,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
March 1935,
Science (New York, N.Y.),
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
March 1956,
Arzneimittel-Forschung,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
May 1955,
Ceskoslovenska farmacie,
A Gorini, and
R Arnaboldi, and
L Vercesi, and
M Dossena
May 1973,
Journal of pharmaceutical sciences,
